March 7, 2018 / 5:20 PM / 5 months ago

BRIEF-Inventiva FY Operating Loss Widens to 20.9 Million Euros

March 7 (Reuters) - Inventiva Sa:

* FY OPERATING LOSS EUR 20.9 MILLION VERSUS EUR 13.0 MILLION YEAR AGO‍​

* FY REVENUE EUR 6.5 MILLION VERSUS EUR 9.4 MILLION YEAR AGO‍​

* CASH, CASH EQUIVALENTS AND CURRENT FINANCIAL INSTRUMENTS AMOUNTED TO €59 MILLION AT DECEMBER 31, 2017

* FY NET LOSS EUR 17.2 MILLION VERSUS EUR 7.0 MILLION YEAR AGO‍​

* ‍CLINICAL DEVELOPMENT OF NEW DRUG CANDIDATE, ABBV-157, IS EXPECTED TO BEGIN IN 2018​

* PARTNERSHIP WITH ABBVIE AND BOEHRINGER INGELHEIM IS ADVANCING ON SCHEDULE

* ‍TOPLINE RESULTS OF PHASE IIB FASST TRIAL ARE EXPECTED ON SCHEDULE AT BEGINNING OF 2019​

* CLINICAL DEVELOPMENT OF NEW DRUG CANDIDATE, ABBV-157, EXPECTED TO BEGIN IN 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below